相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival and associated comorbidities in inclusion body myositis
Elie Naddaf et al.
RHEUMATOLOGY (2022)
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies
Maria Casal-Dominguez et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis
Pritikanta Paul et al.
MUSCLE & NERVE (2021)
Clinical utility of anticytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies
Chiseko Ikenaga et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis
Gina Sangha et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study
Shahar Shelly et al.
NEUROLOGY (2021)
Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups
Alexander G. S. Oldroyd et al.
MUSCLE & NERVE (2020)
Neuropathy in sporadic inclusion body myositis: A multi-modality neurophysiological study
James H. Lee et al.
CLINICAL NEUROPHYSIOLOGY (2020)
Race, Income, and Disease Outcomes in Juvenile Dermatomyositis
Kathryn Phillippi et al.
JOURNAL OF PEDIATRICS (2017)
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies
Iago Pinal-Fernandez et al.
RHEUMATOLOGY (2017)
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
J. B. Lilleker et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Association of inclusion body myositis with T cell large granular lymphocytic leukaemia
Steven A. Greenberg et al.
BRAIN (2016)
Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations
Shan Chen et al.
MUSCLE & NERVE (2016)
Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken
Olivier Benveniste et al.
ACTA NEUROPATHOLOGICA (2015)
DEMOGRAPHIC AND CLINICAL FEATURES OF INCLUSION BODY MYOSITIS IN NORTH AMERICA
A. David Paltiel et al.
MUSCLE & NERVE (2015)
Clinical features of Japanese patients with inclusion body myositis
Hiroko Hori et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Inclusion Body Myositis
Mazen M. Dimachkie et al.
NEUROLOGIC CLINICS (2014)
Evaluation and construction of diagnostic criteria for inclusion body myositis
Thomas E. Lloyd et al.
NEUROLOGY (2014)
Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials
A. Cortese et al.
NEUROMUSCULAR DISORDERS (2013)
188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands
M. R. Rose
NEUROMUSCULAR DISORDERS (2013)
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine
Elena Schiopu et al.
ARTHRITIS RESEARCH & THERAPY (2012)
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities
Fieke M. Cox et al.
BRAIN (2011)
Long-term observational study of sporadic inclusion body myositis
Olivier Benveniste et al.
BRAIN (2011)
Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases
C. Lindberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
Marinos C. Dalakas et al.
BRAIN (2009)
Pilot trial of etanercept in the treatment of inclusion-body myositis
RJ Barohn et al.
NEUROLOGY (2006)
Inclusion body myositis - Clinical features and clinical course of the disease in 64 patients
UA Badrising et al.
JOURNAL OF NEUROLOGY (2005)
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo
UA Badrising et al.
ANNALS OF NEUROLOGY (2002)
Inclusion body myositis in Connecticut - Observations in 35 patients during an 8-year period
KJ Felice et al.
MEDICINE (2001)
A prospective natural history study of inclusion body myositis: Implications for clinical trials
MR Rose et al.
NEUROLOGY (2001)
A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM
MC Dalakas et al.
NEUROLOGY (2001)
Disease progression in sporadic inclusion body myositis: Observations in 78 patients
A Peng et al.
NEUROLOGY (2000)
分享论文
